Inventiva (IVA) EBIT Margin (2019 - 2021)

Inventiva (IVA) posted quarterly EBIT Margin of 21021.54% for Q2 2021, down 904857.0% year-over-year from N/an in Q2 2020, and down 56.47% quarter-over-quarter from 13435.14% in Q1 2021.

Inventiva (IVA) EBIT Margin (2019 - 2021) Analysis & Trends

Inventiva's EBIT Margin history runs 3 years deep, the most recent figure standing at 21021.54% for Q2 2021.

  • In Q2 2021, EBIT Margin fell 904857.0% year-over-year to 21021.54%; the TTM figure through Jun 2021 stood at 10632.57% (changed N/A YoY), while the FY2025 annual figure was 1779.12%, down 111659.0% from the prior year.
  • EBIT Margin for Q2 2021 stood at 21021.54%, down from 13435.14% in the prior quarter.
  • The five-year high for EBIT Margin was 433.15% in Q4 2019, with the low at 21021.54% in Q2 2021.
  • The 3-year median for EBIT Margin is 9980.84% (2020), against an average of 10445.56%.
  • Peak annual rise in EBIT Margin reached 561330 bps in 2021, while the deepest fall reached 904857 bps in 2021.
  • Inventiva's EBIT Margin stood at 433.15% in 2019, then plunged by 1744 bps to 7988.71% in 2020, then tumbled by 163 bps to 21021.54% in 2021.
  • Business Quant data shows IVA's EBIT Margin at 21021.54% in Q2 2021, 13435.14% in Q1 2021, and 7988.71% in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.15%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 31.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 19.06%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -105.20%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.75%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 17.93%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.36%
10 Inventiva 888.89 Mn 888.89 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -21,021.54%
Mar 31, 2021 -13,435.14%
Dec 31, 2020 -7,988.71%
Jun 30, 2020 -11,972.97%
Mar 31, 2020 -7,821.84%
Dec 31, 2019 -433.15%